Comparative evaluation of uricodepressants allopurinol and febuxostat in gouty nephropathy. Message 2. Еxperimental study

Journal Title: Нирки - Year 2018, Vol 7, Issue 3

Abstract

Background. In our previous study (message 1), a comparative evaluation on the efficacy of two uricodepressants, allopurinol and febuxostat, was performed in terms of their effect on the functional state of the kidneys in patients with gouty nephropathy, and the advantage of the latter was established. The purpose of this study: a comparative evaluation of allopurinol and febuxostat effects on the manifestations of experimental gouty nephropathy. Materials and methods. The experiment was performed on 70 white male nonlinear rats. The animals were once injected with Freund’s complete adjuvant with splenic deoxyribonucleic acid of bovine animals and were subsequently kept on a daily diet consisted of autolyzed yeast with ammonium molybdate and inosine, and a sterile suspension of uric acid was injected into their abdominal cavities every 10 days. After 20 days, the rats were divided into 3 groups: group 1, with allopurinol added to daily nutrition; group 2 received febuxostat; group 3, which had not been treated with uricodepressants. The rats were sacrificed under inhalation ether and intraperitoneal nembutal anesthesia. The kidney tissues were examined by means of the light microscopy. Morphological preparations were stained: with hematoxylin and eosin, van Gieson’s and alcian blue, periodic ­acid-Schiff reaction was applied, the average index of the lesion of parti­cular renal structures was calculated. Results. In experimental gouty nephropathy, all kidney structures (glome­ruli, tubules, stroma, vessels) are damaged, the incidence and severity are associated with ongoing uricodepressive therapy; in addition, the xanthine oxidase inhibitor allopurinol and the xanthine oxidoreductase inhibitor febuxostat equally reduce the level of uricemia, but the effect of the former is more focused on tubulointerstitial changes, and the latter — on glomerular, followed by the inhibition of non-protein nitrogen products and medium-weight molecules in the blood. Conclusions. Taking into consideration the previous clinical study, the advantage of febuxostat over allopurinol in gouty nephro­pathy was established.

Authors and Affiliations

O. V. Sinyachenko, T. B. Bevzenko, D. M. Fedorov

Keywords

Related Articles

Target Blood Pressure Level in Diabetes Mellitus Type 2: Evaluation of the Scientific Evidence

The review of the scientific evidence on the control of blood pressure (BP) in patients with diabetes mellitus is given. Their analysis suggests that the optimal level of blood pressure to prevent the development of card...

Application of genetic testing in steroid-resistant nephrotic syndrome

Nephrotic syndrome, one of the most frequent kidney conditions affecting patients of all ages, has significant genetic composition, especially in individuals who do not respond to glucocorticoid treatment. The recent dev...

Moxonidine in the treatment of chronic kidney disease associated with hypertension

Kidney disease pathogenesis is closely related to essential or secondary hypertension. Treatment of chronic kidney disease associated with hypertension requires a comprehensive causal and pathogenetic therapy. The topic...

The role of epithelial-mesenchymal transition in sclerotic changes in the kidneys, ureters and bladder of fetuses and newborns from mothers, whose pregnancy was complicated by preeclampsia of varying severity

Background. Preeclampsia is a frequent complication of pregnancy. The literature data and the results of our own studies indicate the development of morphofunctional changes in the kidneys, ureters and bladder of fetuses...

CAKUT-Syndrome and Chronic Kidney Disease: the Concept of Nephrology Approach

This article presents the results of the analysis of the etiological structure of chronic kidney disease (CKD) in Kyiv children from 2006 to 2015. In the structure of CKD, CAKUT-syndrome dominates — from 62.3 % (2013) to...

Download PDF file
  • EP ID EP369509
  • DOI 10.22141/2307-1257.7.3.2018.140203
  • Views 73
  • Downloads 0

How To Cite

O. V. Sinyachenko, T. B. Bevzenko, D. M. Fedorov (2018). Comparative evaluation of uricodepressants allopurinol and febuxostat in gouty nephropathy. Message 2. Еxperimental study. Нирки, 7(3), 196-201. https://europub.co.uk/articles/-A-369509